MEDI
NEO
saleprice
KONEF
OTC
OUR MISSION

We are looking to change how mental health is treated

Ketamine One exists to make breakthrough treatments more easily accessible and offer patients transformational experiences.

We operate medical clinics across North America to help our patients access plant-based medicines, psychedelics, and other forms of mental health care, all of which have the potential to heal them of their physical and/or emotional pain.

Ketamine 1 Icon

20%

LIVING WITH MENTAL ILLNESS

In 2019, nearly 1 in 5 Americans were living with a mental illness or addiction problem.

Ketamine 1 Icon

20M

AMERICANS WITH ADDICTIONS

Almost 21 million Americans have a drug, tobacco, or alcohol addiction, yet only 10% of them receive treatment.

Ketamine 1 Icon

8.7%

POPULATION EXPERIENCES PTSD

1 of 13 Americans will develop PTSD at some point during their lifetime.

Leadership Team

Ketamine One has compiled a well-rounded leadership team, with vast expertise across medical fields and capital markets.

Adam Deffett

Interim CEO | VP of Capital Markets & Communications

Adam Deffett is a senior capital markets professional with over 15 years of experience in the Canadian equity markets.  Mr. Deffett began his career at RBC Capital Markets and has held senior positions in both sales and trading at various Canadian banks and independent dealers, most recently as Managing Director and Head of Institutional Sales at Laurentian Bank.  He has extensive experience in capital raising, shareholder communication and capital markets strategy.  Mr. Deffett graduated with a Bachelors of Commerce from the University of Calgary and is a CFA Charterholder.

Peter Nguyen

Chief Financial Officer | CPA, CA

Mr. Nguyen has held senior financial positions for several public and private entities where he provides assurance, corporate financing, tax and business advisory services. He has more than 10 years of experience in various financial reporting and business strategy positions.  Mr. Nguyen is a Chartered Professional Accountant and an alumnus of the University of British Columbia.

Dr. Mark Kimmins

Chief Medical Officer | MD

Dr. Kimmins is a medical doctor and surgeon who is a Fellow of the American College of Surgeons, a Fellow of the Royal College of Surgeons of Canada, and a Fellow of the American Society of Colon and Rectal Surgeons. He has extensive experience in academic medicine, subspecialty community medicine, cannabis medicine, and healthcare related business. He is board certified in both the US and Canada, and a citizen of both countries.

Najla Guthrie

Chief Science Officer

Ms. Guthrie joins Ketamine One as part of the previously announced acquisition of KGK Science Inc. from Auxly Cannabis Group Inc., where she has held the role of President & CEO since 1997. Over 23 years, Ms. Guthrie has grown the London-based business to become a leading North American contract research organization that primarily provides high-quality clinical research trials with a focus on the nutraceutical, cannabis and emerging psychedelic industries.  Ms. Guthrie has published over 50 papers in peer-reviewed journals and has given numerous presentations at both the national and international levels.

Keith White

President, Clinic Operations

Mr. White joins Ketamine One as part of the previously announced acquisition of 14 medical cannabis clinics, in the same role held with Aleafia Health to ensure the continuity and ongoing growth of the clinical assets. During his tenure, he led patient growth initiatives that resulted in an 84 per cent annual increase in medical cannabis sales, while rapidly implementing scalable technological solutions to enable patient care to continue virtually during the COVID-19 pandemic. Mr. White is a dynamic executive with over 20 years of senior leadership experience with growth-oriented, private healthcare companies.

Peter Nguyen

Director

Mr. Nguyen has held senior financial positions for several public and private entities where he provides assurance, corporate financing, tax and business advisory services. He has more than 10 years of experience in various financial reporting and business strategy positions.  Mr. Nguyen is a Chartered Professional Accountant and an alumnus of the University of British Columbia.

James Henning

Director

Mr. James Henning is a Chartered Accountant and the founder and president of Corpfinance Advisors Inc. since 1984. Mr. Henning has solid expertise and practical experience in evaluating businesses in a broad range of industries. He has assisted companies in financing, public offerings and restructuring. Areas of expertise include retail cannabis, manufacturing, telecommunications, software, biomedical, oil and gas services, and renewable energy industries. Mr. Henning has served as a Chief Financial Officer and director for a number of TSX Venture Exchange and Canadian Securities Exchange listed companies over the past several years.

Brendan Purdy

Director

Mr. Purdy is a practicing securities lawyer focused on the resource, life sciences, and technology sectors. In his private practice, he has developed extensive experience with respect to public companies, capital markets, mergers and acquisitions, and other transactions fundamental to the Canadian junior equity markets. Prior to receiving his J.D. from the University of Ottawa, Mr. Purdy completed a Bachelor of Management and Organizational Studies degree from the University of Western Ontario, majoring in finance and administration. Mr. Purdy has served as director of several public companies.

Natasha Raey

Director

Ms. Raey is a serial entrepreneur and consultant whose current work is focused on the health care, cannabis and wellness industries. Ms. Raey has managed the planning and development of large-scale health centres in both Vancouver and Toronto. In 2017, she opened Cadence Health Centre, a team-based multidisciplinary health centre and pharmacy in downtown Toronto. In 2014, she co-founded SheTalks Global, an annual speaker series and conference showcasing influential women in diverse fields. Most recently, in 2019, Ms. Raey founded Bloom & Elix, an enterprise developing wellness and brain health supplements for women. She also serves as an independent business, marketing and public relations consultant for a number of social enterprises, public institutions and non-government organizations. Ms. Raey holds a masters of health administration from The University of British Columbia, and BSc, molecular biology and biochemistry (honours), from Simon Fraser University.

Loreto Grimaldi

Director

Mr. Grimaldi is a business and legal executive with 25 years of corporate, transactional, business transformation and corporate governance experience working with several large North American businesses across a wide range of industries.

He is currently Chief Operating and Legal Officer of Tricor Automotive Group Inc., a finance and insurance business in the auto sector. He is also the Co-Founder of Fleets Coffee, a disruptive global food tech business. Most recently, Loreto was SVP General Counsel and Corporate Secretary of ECN Capital Corp., a publicly-traded North American specialty finance business. Prior roles include senior positions at Progressive Waste Solutions, now Waste Connections Inc. (WCN:TO), MedAvail Technologies Inc. (MDVL:NASD), and Symcor Inc.

Loreto began his legal career at Stikeman Elliott LLP, one of Canada's largest law firms. He holds a BBA and an MBA from the Schulich School of Business (York University), and an LL.B from Western University. He is called to the Bar in Ontario and the State of New York, and is an active member of the American Bar Association, the Association of Corporate Counsel, the National Association of Corporate Directors, and the Institute of Corporate Directors.

Steven Inglefield

Director

Mr. Inglefield has over 16 years of experience in the health and wellness sector in both private and public health. A serial entrepreneur and a Physiotherapist by training, Mr. Inglefield has successfully started, managed and exited multiple health companies including multidisciplinary health clinics, corporate wellness services, and personal training studios. He is the founder and Chief Executive Officer of Integrated Rehab and Performance Ltd., a company exclusively catering to the rehabilitation of military veterans, active Canadian Armed Forces and first responders.  

Mr Inglefield is also the Chief Operating Officer of Angela Cote Inc. - a successful franchise consulting company focused on improving the performance of North American franchise systems

Dr. Mark Kimmins

Chairperson

Dr. Kimmins is a medical doctor and surgeon who is a Fellow of the American College of Surgeons, a Fellow of the Royal College of Surgeons of Canada, and a Fellow of the American Society of Colon and Rectal Surgeons. He has extensive experience in academic medicine, subspecialty community medicine, cannabis medicine, and healthcare related business. He is board certified in both the US and Canada, and a citizen of both countries.

Dr. Quang Henderson

Medical Advisory Member

Dr. Quang Henderson is the Founder and Medical Director of MindScape Ketamine & Infusion Therapy, PLLC. He is a licensed Board-Certified Emergency Physician with over 20 years of experience in utilizing ketamine. Dr. Henderson co-founded Neighbors Emergency Centers and previously served on its Board and as Medical Director for several of its facilities. He is passionate about making intravenous ketamine a viable option to those suffering with severe depression, bipolar depression, post traumatic stress disorder, psychiatric disorders and chronic pain. Quang attended Texas A&M University pursuing a degree in Biochemistry. He obtained his Doctor of Medicine degree from The University of Texas Medical Branch. Dr. Henderson completed his Emergency Medicine Residency at UT Houston Health Science Center/Hermann Hospital. He currently also holds the position of Chairperson of Clinical Innovation Council for Ketamine One.

Dr. Dennis Filips

Medical Advisory Member

Dr. Dennis Filips is the principal founder and Chief Medical Officer of Innovative Trauma Care. Dr. Filips, a trauma surgeon, retired from the Canadian Forces after 20 years of service and completing tours in Afghanistan, Bosnia, and the Golan Heights. He completed an Executive MBA program at the Telfer School, University of Ottawa in May 2020. Dennis was an Assistant Adjunct Professor at the National Defense University in Washington DC where he taught Healthcare Industry Studies. He also worked as a general/trauma surgeon in Edmonton and Toronto and as a course director for Advanced Trauma Life Support and Tactical Medicine courses for the military and tactical police units. Dr. Filips completed a trauma fellowship at Sunnybrook & Women’s College Health Sciences in Toronto, Ontario in 2002, his general surgery residency at the University of Toronto in 2001 and medical school at Queen’s University in 1991.

Dr. Darren Cotterell

Medical Advisory Member

Dr. Darren Cotterell is a geriatric psychiatrist based in Chichester, England. He has obtained multiple psychiatric credentials, including but not limited to an MRCPsych from the United Kingdom in 2006 and a Specialist Certification in Psychiatry form the Royal College of Physicians and Surgeons Canada in 2014. Darren has held the role of Old Age Psychiatrist with Sussex Partnership NHS Foundation Trust since September of 2020. Previously, he held the role of Geriatric Psychiatrist with Island Health of the Vancouver Island Health Authority, which began in June of 2011. Prior to his time on Vancouver Island, Dr. Cotterell held a similar role with Solent NHS Trust in Portsmouth, England from July of 2010. Darren received his Master’s Degree (with Distinction) in Clinical Neuroscience from the University of Roehampton in 2010, subsequent to earning a Bachelor of Medicine, Bachelor of Surgery – MBBS, Medicine from the University of the Witwatersand in 1998.

Dr. Glen Brooks

Medical Advisory Member

Dr. Glen Brooks, MD, a board-certified anesthesiologist and pioneer in his field, eight years ago recognized the tremendous need for a treatment that could provide rapid relief to those suffering from life threatening mood disorders and central neuropathic pain. He is now the Founder and Medical Director of NY Ketamine Infusions, one of the first treatment centers dedicated exclusively to providing ketamine therapy. Dr. Brooks treats patients with mental health conditions, including major depressive disorder, generalized anxiety, post traumatic stress disorder, obsessive compulsive disorder and chronic neuropathic pain.

He has treated over 3,000 patients and coordinates infusion treatments with each individual’s referring psychiatrist or therapist. Dr. Brooks completed his training at Harvard’s Brigham and Women’s Hospital and taught at Yale University School of Medicine.


Dr. Ravi Bains

Medical Advisory Member

Dr. Ravi Bains earned a bachelor’s degree in psychology prior to studying medicine in his home province at the University of Manitoba. He completed a psychiatric residency at Dalhousie University, where he went on to complete a fellowship in Intensive Short Term Dynamic Psychotherapy. After graduating in 2006, Dr. Bains has practiced as an inpatient psychiatrist and a psychotherapist. He has developed a passion for promoting body/mind/spirit health, ‘deprescribing’ and working with trauma.

Acutely aware of the limits of conventional psychiatry, Ravi has also developed a strong interest in the potential of psychedelic medicines such as ketamine and psilocybin. He is currently CMO for Wayfound Mental Health Group as well as ATMA Journey Centers.

NEWS Releases

Latest News & Updates from Ketamine One

Load More
Awesome, you subscribed!
Error! Please try again.